Navigation Links
CSHL researchers solve structure of human protein critical for silencing genes
Date:5/25/2012

rwise flexible Argonaute protein and gives it stability."

The researchers speculate that the path threaded through the Argonaute by the guide RNAs could have evolved to maximize mutual stability, in turn making the protein-RNA complexes long-lived. This long life is critical for many biological processes that are mediated by Argonautes. "This is also the kind of information that might help us to design better synthetic guide RNAs for therapeutic use," explains Joshua-Tor. "It will also be useful to researchers who are trying to find more precise ways of blocking Argonaute activity."


'/>"/>

Contact: Hema Bashyam
bashyam@cshl.edu
516-367-6822
Cold Spring Harbor Laboratory
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Researchers identify genetic markers to predict male fertility
2. University of Hawaii Cancer Center researchers create new anti-cancer drug
3. UCLA researchers develop way to strengthen proteins with polymers
4. Tufts Medical Center researchers finds marker in premies saliva predicts readiness to feed by mouth
5. Researchers aim to assemble the tree of life for all 2 million named species
6. Dartmouth researchers are learning how exercise affects the brain
7. Nottingham researchers lead worlds largest study into pre-eclampsia
8. Begin early: Researchers say water with meals may encourage wiser choices
9. Researchers look to relatives for clues in quest to develop sources of bioenergy
10. WSU researchers say genes and vascular risk modify effects of aging on brain and cognition
11. KIT researchers succeed in realizing a new material class
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CSHL researchers solve structure of human protein critical for silencing genes
(Date:7/13/2015)... , July 13, 2015 Synaptics Inc. ... human interface solutions, today announced sampling of ClearPad ... display driver integration (TDDI) product targeting smartphones and ... to combine Synaptics , best-in-class touch controller ... driver technology developed in the company,s Japan Design ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
(Date:7/7/2015)... , June 30, 2015 ... has announced the addition of the "Capacitive ... offering. To this date, fingerprint sensing ... technology and fingerprint sensors are well developed. This ... sensing technology. The domain of capacitive ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... EAST LANSING, Mich. Researchers at Michigan State University ... natural killer cells fight bacterial infection and reduce inflammation, ... are fiber supplements that serve as food for the ... taken, they can stimulate the growth of the "good" ...
... PhD, research group leader at the new Max Planck ... The Michael J. Fox Foundation for Parkinson,s Research (MJFF). ... to develop a technology that will help scientists working ... LRRK2, a Parkinson,s-related gene. Globally, five million people have ...
... presented at Europe,s leading breast cancer translational research conference ... differences between individual breast cancers. Focused on ... sensitive to important therapies, the new studies will help ... for millions of patients. "Despite major advances in ...
Cached Biology News:Researchers show prebiotic can reduce severity of colitis 2Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinson's drug development tools 2Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinson's drug development tools 3New data improve understanding of breast cancer's multiple varieties 2New data improve understanding of breast cancer's multiple varieties 3New data improve understanding of breast cancer's multiple varieties 4New data improve understanding of breast cancer's multiple varieties 5New data improve understanding of breast cancer's multiple varieties 6
(Date:7/30/2015)...  Discovery Laboratories, Inc. (Nasdaq: DSCO ) ... $1.0M tranche under a previously awarded Phase II ... up to $3.0 million to support continued development ... potential medical countermeasure to mitigate acute and chronic/late-phase ... initial $1.0 million under this grant in October ...
(Date:7/29/2015)... 2015 Sanofi, a global ... second quarter of 2015. CEO Olivier Brandicourt ... performance in different businesses. Watch video ... Topics covered in the interview ... - Performance drivers - Diabetes ...
(Date:7/29/2015)... July 29, 2015 US-Australian drug discovery company, ... confirmed it is committed to progressing its ground-breaking technology ... practicable and to ensure the Company delivers the best ... Iain Ross , said the Company currently had ... pre-clinical programs, discovery programs and academic partnerships and initiatives, ...
(Date:7/29/2015)... July 29, 2015  HealthSouth Corporation ... largest providers of post-acute healthcare services, offering both ... results of operations for the second quarter ended ... was characterized by strong volume growth in both ... EBITDA," said Jay Grinney, President and Chief Executive ...
Breaking Biology Technology:Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25
... as Action Date, IRVINE, Calif., Sept. 13 ... the amendment to,the New Drug Application (NDA) for ISO-Vorin(TM) ... the U.S. Food & Drug Administration,(FDA). The FDA has ... approval of the ISO-Vorin(TM) application. ISO-Vorin(TM) is the pure,active ...
... COPENHAGEN, September 13 Genmab A/S (OMX:,GEN) announced ... with,Medarex, Inc. Under the terms of the agreement, ... IL-8, and Medarex will,receive full rights to multiple ... to each other all previously held economic interests,in ...
... of Energys Brookhaven National Laboratory have developed a new ... particles. The method, based on designed DNA shells that ... the structure and therefore the properties and potential ... interest to industry. For example, such fine-tuning of materials ...
Cached Biology Technology:FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals 2FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals 3Genmab Announces Asset Exchange Agreement 2New DNA-based technique for assembly of nano- and micro-sized particles 2
1+ mg expected yield of purified protein, expressed in insect cells - excludes cDNA...
...
Request Info...
... Cultrex High Protein Concentration Basement ... for use in in vivo applications ... gelling times, increased gel strength, and ... HC20+ has the advantage of lot-to-lot ...
Biology Products: